Regression Testing & System Qualification for CDS Applications

This contract involves performing regression testing and system qualification on the Empower and NuGenesis clinical decision support (CDS) applications following their migration. The goal is to verify that these applications maintain full functionality, ensure data integrity, and comply with FDA validation standards. The work is critical to confirm the systems continue to meet all regulatory requirements post-migration. The contract is a subcontract issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. It is classified under NAICS code 541380 and requires completion of testing in Detroit, Michigan, ZIP code 48207. The contract was posted on June 3, 2026, with a response deadline of June 18, 2026. This effort supports the FDA’s continued assurance of reliable and validated CDS software tools important to regulatory compliance and public health.